ArTS Archivio della ricerca di Trieste

POZZATO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.946
EU - Europa 10.277
AS - Asia 9.196
SA - Sud America 1.345
AF - Africa 214
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 20
Totale 41.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.648
SG - Singapore 3.349
PL - Polonia 2.100
CN - Cina 2.062
UA - Ucraina 1.586
IT - Italia 1.396
SE - Svezia 1.212
HK - Hong Kong 1.126
BR - Brasile 1.053
VN - Vietnam 889
DE - Germania 781
FI - Finlandia 725
FR - Francia 593
KR - Corea 591
RU - Federazione Russa 419
GB - Regno Unito 385
IE - Irlanda 293
TR - Turchia 285
BG - Bulgaria 281
BD - Bangladesh 267
IN - India 158
CA - Canada 153
NL - Olanda 134
AR - Argentina 102
MX - Messico 88
JP - Giappone 87
CH - Svizzera 66
BE - Belgio 59
PK - Pakistan 59
MA - Marocco 54
ES - Italia 50
IQ - Iraq 50
EC - Ecuador 48
ZA - Sudafrica 41
AU - Australia 35
CO - Colombia 33
ID - Indonesia 32
PH - Filippine 32
SA - Arabia Saudita 32
AT - Austria 31
CZ - Repubblica Ceca 30
VE - Venezuela 30
EG - Egitto 29
CL - Cile 28
RO - Romania 26
IR - Iran 21
PY - Paraguay 19
UZ - Uzbekistan 18
JO - Giordania 17
SN - Senegal 17
KE - Kenya 16
TN - Tunisia 16
EU - Europa 14
TW - Taiwan 14
GR - Grecia 13
IL - Israele 12
PT - Portogallo 12
DZ - Algeria 10
HR - Croazia 10
KZ - Kazakistan 10
PE - Perù 10
UY - Uruguay 10
BO - Bolivia 9
DK - Danimarca 9
LU - Lussemburgo 9
NO - Norvegia 9
TH - Thailandia 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CR - Costa Rica 8
LT - Lituania 8
MY - Malesia 8
PA - Panama 8
NP - Nepal 7
BY - Bielorussia 6
HU - Ungheria 6
JM - Giamaica 6
KG - Kirghizistan 6
OM - Oman 6
RS - Serbia 6
AO - Angola 5
HN - Honduras 5
SY - Repubblica araba siriana 5
DO - Repubblica Dominicana 4
GD - Grenada 4
LB - Libano 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
AL - Albania 3
CI - Costa d'Avorio 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 40.981
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.961
Singapore 1.875
Ann Arbor 1.823
Warsaw 1.816
Ashburn 1.642
Fairfield 1.530
Jacksonville 1.394
Houston 1.386
Chandler 1.253
Hong Kong 1.109
San Jose 1.038
Wilmington 876
Hefei 636
Seoul 579
Seattle 574
Princeton 537
Cambridge 506
Boardman 433
Beijing 377
Chicago 345
Trieste 339
Dublin 290
Sofia 277
Columbus 264
Munich 257
Zgierz 257
Ho Chi Minh City 246
Lauterbourg 243
Izmir 242
Dallas 231
Helsinki 225
Hanoi 211
Los Angeles 196
Moscow 187
The Dalles 168
Santa Clara 150
Buffalo 147
Milan 129
Council Bluffs 104
Düsseldorf 103
San Diego 102
Dearborn 101
São Paulo 96
New York 92
Frankfurt am Main 81
London 68
Redwood City 59
Bern 56
Toronto 55
Orem 53
Brussels 51
Guangzhou 47
Phoenix 47
Porto Alegre 45
Shanghai 45
Haiphong 42
Norwalk 41
Verona 41
Tokyo 40
Tianjin 39
Da Nang 38
Turku 35
Rio de Janeiro 34
Casablanca 32
Denver 31
Redondo Beach 31
Atlanta 30
Brooklyn 30
Dong Ket 30
Montreal 30
Des Moines 29
Kunming 28
Chennai 27
Jinan 27
Sacile 27
Mestre 26
Ottawa 25
Falls Church 24
Nanjing 24
Belo Horizonte 23
Hangzhou 23
Nuremberg 23
Padova 23
Rome 23
Washington 23
Mumbai 22
Stockholm 22
Baghdad 21
Boston 21
Duino-Aurisina 21
Grafing 21
Lahore 21
Quito 21
Johannesburg 20
Amsterdam 19
Brasília 18
Brno 18
Manchester 18
Mexico City 18
San Francisco 18
Totale 28.152
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 495
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 477
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival 476
Potential applications of nanocellulose-containing materials in the biomedical field 467
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 447
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines 424
Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options. 407
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 404
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 371
Mutations in the 3' untranslated region (3' UTR) of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 345
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 343
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases 333
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 306
The role of the transcription factor E2F1 in hepatocellular carcinoma 298
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 288
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 286
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 283
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 281
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 274
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 273
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 263
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 254
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 249
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components 248
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application. 246
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 242
DEFB1 polymorphisms and salivary hBD-1 concentration in Oral Lichen Planus patients and healthy subjects 242
Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration 241
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 241
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 240
A case of burkitt-like B lymphoblastic lymphoma 239
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 238
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism. 236
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. 236
Translation Elongation 236
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 233
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 228
A transient cutaneous relapse of AML M1 in hematological remission: A case report 223
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 221
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway 219
Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. 218
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 216
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 212
Introduction 212
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 207
Randomized trial of combination therapy in relapser or non-responder HCV patients 205
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia 203
S-adenosylmethionine counteracts oral contraceptive hepatotoxicity in women 201
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 196
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage. 195
Bortezomib effect of E2F and cyclin family members in human hepatocellular carcinoma cell lines 195
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 195
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles ofTP53disrupted chronic lymphocytic leukaemia cells 193
A new genotype: typical of Italy? 193
TP53 mutations with low variant allele frequency predict short survival in Chronic Lymphocytic Leukemia 192
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 190
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells 187
Effects of chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles on a human/mouse model of Burkitt lymphoma 186
Abnormality in the hepatic transport of Rifamycin-SV in Gilbert's syndrome 185
Improving siRNA Bio-Distribution and Minimizing Side Effects 183
A randomized trial comparing different alfa-interferon at different dose and duration as therapy for chronic hepatitis C. 181
Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands? 179
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 179
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. 178
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. 178
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 177
A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B 176
No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV 176
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 176
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study 176
Acute high-dose ethanol modulates glutathione levels to different degrees in various organs of the rat. 174
A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. 174
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 173
ALCOHOL HEPATIC TOXICITY IN RAT: EVIDENCE OF THE UTILITY OF THE GASTRIC ETHANOL METABOLISM 172
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells 172
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer 171
Merkel-cell polyomavirus and B-cell chronic lymphocytic leukemia 170
Hematologic problems in the Critically III 170
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 169
Abnormal serum gamma-glutamyltranspeptidase in alcoholics: clues to its explanation 169
Influence of acid-secretion blockers on gastric and hepatic alcohol dehydrogenase in rat 166
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. 166
Cirrhotic thrombocytopenia is a multifactorial condition: evidence of reduced platelet production and incresed platelet destruction 165
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 164
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C. 163
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: relationship to the severity of liver disease and response to the alpha-interferon therapy. 162
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 160
Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy 159
Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. 158
Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials 158
B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinemia syndrome and hepatitis-C virus infection 157
Gastric and hepatic glutathione after ethanol load: the role of first-pass metabolism and effects of antisecretive drugs. 157
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas 156
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia 156
Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. 155
Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. 154
Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. 154
Influence of ascitic fluid characteristics on coagulation disorders after implantation of Le Veen peritoneo-jugular shunt. 154
"True" histiocytic lymphoma of the stomach associated with colonic cancer and complicated by chronic myeloid leukemica 152
Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction. 150
Totale 22.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.722 71 235 151 344 42 156 100 139 367 304 166 647
2022/20233.443 376 378 295 454 374 646 29 263 406 36 125 61
2023/20242.013 165 132 84 98 159 154 296 503 21 63 162 176
2024/20254.890 117 144 308 392 412 464 353 373 824 618 398 487
2025/202611.630 858 691 915 995 1.004 1.208 1.797 401 1.329 1.513 528 391
2026/202734 34 0 0 0 0 0 0 0 0 0 0 0
Totale 41.630